Your session is about to expire
← Back to Search
Behavioural Intervention
Behavioral Skills Intervention for Autism Spectrum Disorder
N/A
Recruiting
Led By Jill Locke, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Autistic students aged 5-12 from a participating public elementary school with school documentation of an autism classification, confirmed ASD diagnosis, and above-mean score on Emotion Dysregulation Inventory or Sutter Eyberg Student Behavior Inventory, enrolled in a Kindergarten-5th grade general or special education classroom, participate in an inclusive classroom setting for a minimum of 10% of their weekly hours, and have a participating educator enrolled that meets the inclusion criteria for Elementary School Personnel
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 12, and week 24
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to improve outcomes for autistic children in public schools by redesigning and testing a new strategy to support educators in using evidence-based interventions. The current lack of efficient implementation strategies hinders the availability
Who is the study for?
This trial is for educators in public schools who work with autistic children. The goal is to improve the use of behavioral skills interventions (EBI) in educational settings, addressing the urgent need for effective autism support.
What is being tested?
The study tests a redesigned implementation strategy called RUBIES-Team, compared to an unadapted strategy, aiming to better integrate EBIs like RUBI into schools for autistic youth.
What are the potential side effects?
Since this trial involves educational strategies rather than medical treatments, there are no traditional side effects. However, there may be challenges or resistance encountered when implementing new practices.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an autistic student aged 5-12, with confirmed ASD and struggle with managing emotions or behavior, attending K-5th grade, spending some time in inclusive classes, and my teacher is participating.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, week 12, week 24
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 12, week 24
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
24-item Emotion Dysregulation Inventory
Aberrant Behavior Checklist-Irritability Scale (ABC-I)
Adoption
+5 moreSecondary study objectives
Clinical Global Impressions (CGI)
Fidelity
Number of participants who complete the Framework for Modifications and Adaptations of Evidence Based Interventions
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: RUBI in Educational Settings (RUBIES) implementation strategyExperimental Treatment1 Intervention
Participants in this arm will receive an adapted version of the RUBI intervention manual that was iteratively redesigned for use in educational settings (i.e., RUBI for Educational Settings; RUBIES)
Group II: Unadapted Research Units in Behavioral Intervention (RUBI) implementation strategyActive Control1 Intervention
Participants in this arm will receive the un-adapted RUBI implementation strategy (i.e., RUBI as usual).
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,814 Previous Clinical Trials
1,912,873 Total Patients Enrolled
17 Trials studying Autism Spectrum Disorder
4,118 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,913 Previous Clinical Trials
2,738,375 Total Patients Enrolled
84 Trials studying Autism Spectrum Disorder
41,092 Patients Enrolled for Autism Spectrum Disorder
Jill Locke, PhDPrincipal InvestigatorUniversity of Washington
2 Previous Clinical Trials
750 Total Patients Enrolled
1 Trials studying Autism Spectrum Disorder
350 Patients Enrolled for Autism Spectrum Disorder
Share this study with friends
Copy Link
Messenger